Clinicians and patients push Mass. bill HB1134 to expand pain care coordination and nonopioid access

Clinicians, patient advocates and people living with chronic pain urged the Massachusetts committee to favorably report House Bill 1134, saying it would expand care coordination, require data collection on chronic pain and limit insurer restrictions on nonopioid medications for MassHealth members.

Supporters described chronic pain as a complex, multisystem condition that often requires multidisciplinary treatment and more time in primary care than currently available. They said the bill’s provisions would reduce long-term costs and improve outcomes by expanding access to comprehensive, evidence-based therapies.

Betsy O'Donnell, a medical oncologist and director of early detection and prevention at Dana-Farber Cancer Institute, testified that firefighters face elevated cancer risks and separately urged coverage for early detection for firefighters; during her remarks she also framed the public-health importance of early detection and prevention generally. Jackie Nathan, a nurse practitioner and board member of the Massachusetts Pain Initiative, testified in support of HB1134 and outlined barriers clinicians and patients face under current insurance rules.

"This bill will ensure that for patients with Medicaid insurance, access to nonopioid medications cannot be more restrictive than access to opioid medications," Nathan said, adding that a multidisciplinary approach and training for primary care providers are central to the bill’s goals.

Rebecca West, who lives with chronic pain due to endometriosis and lupus, described repeated stigma and barriers to care, saying patients often face disbelief and restrictions that can lead to depression, loss of income and destabilized family life. She described the bill’s data-collection provisions as a way to measure prevalence, utilization and cost to improve care.

Speakers emphasized three elements: (1) care coordination for MassHealth members to help them navigate providers and social services; (2) training and support so primary care clinicians can offer multidisciplinary options; and (3) a prohibition on insurers applying stricter access controls to nonopioid medications than to opioids.

The hearing included patient testimony about lived experience and provider testimony about administrative barriers such as prior authorizations and limited specialist availability. No formal committee action or vote was reported during the session; witnesses asked the committee to favorably report HB1134.

Ending: Advocates said HB1134 would be a step toward treating chronic pain as a chronic disease requiring coordinated, multidisciplinary care and urged prompt legislative action.